Diabetes Clinical Trials in Kansas City, MO

29 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Type 1 Diabetes Extension Study	—	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
Bionic Pancreas in CFRD	Phase 3	Jaeb Center for Health Research	<1 mi
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus	Phase 2	Hanmi Pharmaceutical Company Limited	<1 mi
TrialNet Pathway to Prevention of T1D	—	University of South Florida	<1 mi
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease	Phase 2	Regeneron Pharmaceuticals	<1 mi
Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity	Phase 2	Kailera	<1 mi
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes	Phase 2	SAb Biotherapeutics, Inc.	<1 mi
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease	Phase 2	Novo Nordisk A/S	<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	<1 mi
Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families	N/A	Nemours Children's Clinic	<1 mi
Registry for Stage 2 Type 1 Diabetes	—	Sanofi	<1 mi
Effectiveness of and Implementation Strategies for 'Disfrutando'.	N/A	University of Missouri-Columbia	<1 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)	Phase 1/2	COUR Pharmaceutical Development Company, Inc.	<1 mi
Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)	N/A	Children's Mercy Hospital Kansas City	<1 mi
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes	Phase 3	Sanofi	<1 mi
Social Determinants and a Diabetes Prevention Program Tailored for African Americans	Phase 2	University of Missouri, Kansas City	<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis	Phase 2/3	CSL Behring	<1 mi
Mitigating the Pro-inflammatory Phenotype of Obesity	Phase 1	University of Kansas Medical Center	3 mi
Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function	Phase 2	University of Kansas Medical Center	3 mi
TArgeting Type 1 Diabetes Using POLyamines (TADPOL)	Phase 2	Emily K. Sims	3 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes	Phase 2	Zucara Therapeutics Inc.	3 mi
Rural Alliance for Diabetes Prevention	N/A	University of Kansas Medical Center	3 mi
Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II Diabetes	Phase 4	University of Kansas Medical Center	3 mi
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes	Phase 4	Brigham and Women's Hospital	6 mi
Fenofibrate for Prevention of DR Worsening	Phase 3	Jaeb Center for Health Research	8 mi
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)	Phase 3	Pfizer	9 mi
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes	Phase 3	vTv Therapeutics	13 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.